menu
Press Release
| December 13, 2019

Q2 Solutions Expands Capabilities in Singapore

Morrisville, N.C. – December 13, 2019 – Q2 Solutions, a leading clinical trial laboratory services organization, proudly announces the relocation and expansion of its clinical trial testing operations in Singapore.  This expansion supports the strong presence of pharmaceutical research in Asia and assures the organization is structured to meet the needs of customers and market growth potential.

The demand for clinical trial laboratory services in Asia, through the Q2 Solutions Singapore laboratory, has increased steadily. As such, this new and expanded Singapore facility provides customers with continued confidence in its ability to meet the demand today and in the future. The new facility provides for an expansion of anatomical pathology (AP), flow cytometry, and molecular biology capabilities and capacity.  In addition to a larger laboratory testing footprint, the new facility provides for an expansion of biorepository capabilities via increased floor space and additional freezers. 

“I am honored to be part of a company that is willing to make such important investments ahead of the demand curve, so we can help assure our customers’ needs are met,” said Jenny Zhang, VP and General Manager, Asia-Pacific. “Feedback from employees and customers has been outstanding, and I am grateful for all of the hard work that went into making this expansion a reality.  We are not finished expanding in Singapore yet, and we now have the space necessary to continue to develop our capabilities and support our customers in a new state-of-the-art facility.”


About Q2 Solutions
Q2 Solutions is a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions. With a relentless focus on quality and innovation, Q2 Solutions uses its global experience and scientific expertise to transform science and data into actionable medical insights that help customers improve human health. Q2 Solutions’ industry-leading genomic and bioinformatics services provide customers with DNA and RNA sequencing and other testing as well as the ability to mine data for invaluable insights for drug discovery, precision medicine and clinical development. Q2 Solutions works with clients, using a wide array of technology platforms, to ensure maximum efficiency and quality delivery for every study. A joint venture of IQVIA (formerly QuintilesIMS) and Quest Diagnostics, Q2 Solutions combines the best of each parent organization’s clinical trials laboratory services capabilities to fulfill its mission of treating each sample as if a life depends on it. To learn more, visit www.q2labsolutions.com.